GKOS
Price:
$143.65
Market Cap:
$7.92B
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Infinite, a three stents product that is designed for use as a standalone procedure in patients with refractory glaucoma; and iDose TR, a targeted injectable implant based on its micro-scale device-platform that is designed to deliver therapeutic levels of medication. The ...[Read more]
Industry
Medical - Devices
IPO Date
2015-06-25
Stock Exchange
NYSE
Ticker
GKOS
According to Glaukos Corporation’s latest financial reports and current stock price. The company's current Enterprise Value is 7.98B. This represents a change of 42.44% compared to the average of 5.60B of the last 4 quarters.
The mean historical Enterprise Value of Glaukos Corporation over the last ten years is 1.95B. The current 7.98B Enterprise Value has changed 40.77% with respect to the historical average. Over the past ten years (40 quarters), GKOS's Enterprise Value was at its highest in in the September 2024 quarter at 7.23B. The Enterprise Value was at its lowest in in the June 2015 quarter at 1.18M.
Average
1.95B
Median
1.99B
Minimum
419.56M
Maximum
4.14B
Discovering the peaks and valleys of Glaukos Corporation Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 167.65%
Maximum Annual Enterprise Value = 4.14B
Minimum Annual Increase = -47.16%
Minimum Annual Enterprise Value = 419.56M
Year | Enterprise Value | Change |
---|---|---|
2023 | 4.14B | 77.29% |
2022 | 2.34B | -0.40% |
2021 | 2.34B | -33.45% |
2020 | 3.52B | 72.28% |
2019 | 2.04B | 5.61% |
2018 | 1.94B | 125.84% |
2017 | 857.36M | -23.65% |
2016 | 1.12B | 167.65% |
2015 | 419.56M | -47.16% |
2014 | 793.96M | 0.80% |
The current Enterprise Value of Glaukos Corporation (GKOS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
2.94B
5-year avg
2.88B
10-year avg
1.95B
Glaukos Corporation’s Enterprise Value is greater than OrthoPediatrics Corp. (602.68M), greater than CONMED Corporation (3.19B), greater than LivaNova PLC (3.18B), greater than Paragon 28, Inc. (934.63M), greater than Orthofix Medical Inc. (853.50M), greater than NuVasive, Inc. (2.84B), greater than Heska Corporation (1.26B), less than Bruker Corporation (10.93B), greater than Nevro Corp. (346.98M), greater than Integer Holdings Corporation (5.85B), greater than IRadimed Corporation (632.02M), greater than Surmodics, Inc. (558.60M), greater than Sight Sciences, Inc. (119.23M),
Company | Enterprise Value | Market cap |
---|---|---|
602.68M | $629.13M | |
3.19B | $2.29B | |
3.18B | $2.85B | |
934.63M | $863.16M | |
853.50M | $746.32M | |
2.84B | $2.08B | |
1.26B | $1.31B | |
10.93B | $8.79B | |
346.98M | $172.37M | |
5.85B | $4.71B | |
632.02M | $683.48M | |
558.60M | $565.16M | |
119.23M | $202.51M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Glaukos Corporation using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Glaukos Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Glaukos Corporation's Enterprise Value?
What is the highest Enterprise Value for Glaukos Corporation (GKOS)?
What is the 3-year average Enterprise Value for Glaukos Corporation (GKOS)?
What is the 5-year average Enterprise Value for Glaukos Corporation (GKOS)?
How does the current Enterprise Value for Glaukos Corporation (GKOS) compare to its historical average?